Ant Group’s AQ Launches DeepSearch to Streamline Clinical Decision-Making
Event summary
- Ant Group’s AI health service AQ introduced DeepSearch, a new AI-driven clinical decision support tool for clinicians and medical students.
- DeepSearch integrates over 36 million high-quality Chinese and international medical publications to support evidence-based treatment planning.
- AQ’s PC platform now offers Health Q&A and DeepSearch, reducing clinicians’ workload and improving access to medical information.
- AQ has 30 million monthly active users and handles over 10 million health-related queries daily as of January 2026.
The big picture
Ant Group’s DeepSearch upgrade positions AQ as a key player in AI-driven clinical decision support, aligning with the broader trend of digital transformation in healthcare. The tool’s ability to synthesize vast amounts of medical literature could set a new standard for evidence-based treatment planning, potentially influencing global healthcare practices. With AQ’s rapid user growth and extensive partnerships, the platform is poised to further disrupt traditional healthcare delivery models.
What we're watching
- Adoption Pace
- How quickly clinicians and medical students will integrate DeepSearch into their workflows, given its free availability.
- Competitive Response
- Whether existing clinical decision support tools will enhance their AI capabilities to match DeepSearch’s functionality.
- Regulatory Scrutiny
- The extent to which health authorities will scrutinize AI-driven clinical decision tools for compliance with medical standards.
Related topics